Trials / Completed
CompletedNCT05119920
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream BID for the Treatment of Signs and Symptoms of Dry Eye Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 226 (actual)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Signs and Symptoms of Dry Eye Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pilocarpine Ophthalmic Topical Cream, Dose 1 | Pilocarpine Ophthalmic Topical Cream, Dose 1 |
| DRUG | Pilocarpine Ophthalmic Topical Cream, Dose 2 | Pilocarpine Ophthalmic Topical Cream, Dose 2 |
| DRUG | Pilocarpine Ophthalmic Topical Cream, Dose 3 | Pilocarpine Ophthalmic Topical Cream, Dose 3 |
| DRUG | Placebo Ophthalmic Topical Cream | Placebo Ophthalmic Topical Cream |
Timeline
- Start date
- 2022-01-03
- Primary completion
- 2022-07-27
- Completion
- 2022-07-27
- First posted
- 2021-11-15
- Last updated
- 2023-07-12
Locations
19 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05119920. Inclusion in this directory is not an endorsement.